Nitromemantine (developmental code names YQW-36 and EM-036), also known as NitroSynapsin, is a derivative of memantine developed in 2006 for the treatment of Alzheimer's disease.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.